Q3 2023 EPS Estimates for Solid Biosciences Inc. Lifted by Analyst (NASDAQ:SLDB)

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2023 earnings per share (EPS) estimates for Solid Biosciences in a research note issued to investors on Wednesday, August 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($1.05) per share for […]

Related Keywords

United States ,Leerink Partnrs ,Solid Biosciences Inc ,Vanguard Group Inc ,Renaissance Technologies ,Nasdaq ,Solid Biosciences Company Profile ,Alyeska Investment Group ,Millennium Management ,Solid Biosciences ,Free Report ,Solid Bioscience ,Street Corp ,Get Free Report ,Biosciences Inc ,Solid Biosciences Daily ,Nasdaq Sldb ,Sldb ,Medical ,Earnings Estimates ,